Promodent Medico Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.40%
- Profit Growth -73.61%
- Ebitda 3.50%
- Net Worth 2.96%
- Total Assets -30.74%
About Promodent Medico
Promodent Medico Private Limited (PMPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 2013 and has a history of 12 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vaibhaw Singh and Sujatha Sathe serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93030MH2013PTC240136
- Company No.
240136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Promodent Medico Private Limited offer?
Promodent Medico Private Limited offers a wide range of products and services, including Suction Machine, Surgical Suction Equipment, Dentist Tools, Equipment & Supplies, Dental Equipment, Dental Products, Dental Chairs, Disposable Gloves, Examination Gloves, Face Mask, Cotton Face Mask.
Who are the key members and board of directors at Promodent Medico?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhaw Singh | Director | 26-Aug-2024 | Current |
Sujatha Sathe  | Director | 01-Feb-2013 | Current |
Financial Performance of Promodent Medico.
Promodent Medico Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.4% increase. The company also saw a substantial fall in profitability, with a 73.61% decrease in profit. The company's net worth moved up by a moderate rise of 2.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Promodent Medico?
In 2020, Promodent Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Promodent Medico?
Unlock and access historical data on people associated with Promodent Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Promodent Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promodent Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
